Q1 2021 Holdings
Filed 2021-05-17 | 83 holdings | $449.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $79.2M | 1,532,960 | 17.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $78.9M | 729,420 | 17.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $49.7M | 4,886,440 | 11.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $45.4M | 1,174,820 | 10.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $38.7M | 71,460 | 8.6% |
| Conmed Corp(CNMD) | COM | 207410101 | $36.2M | 276,940 | 8.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $23.2M | 900,490 | 5.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $22.5M | 80,510 | 5.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $17.5M | 494,640 | 3.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $17.2M | 227,450 | 3.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $15.1M | 536,970 | 3.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $12.3M | 950,000 | 2.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.8M | 462,500 | 2.4% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $552.0K | 13,540 | 0.1% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $158.8K | 1,725,650 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $143.2K | 666,460 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $121.6K | 759,680 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $120.6K | 535,670 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $105.4K | 251,390 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $94.0K | 796,110 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $93.0K | 1,144,287 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $92.3K | 473,330 | 0.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $86.0K | 2,412,712 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $82.3K | 1,005,316 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $78.2K | 414,990 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $77.6K | 401,690 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $68.9K | 583,290 | 0.0% |
| Petco Health & Wellness Co I(WOOF) | COM | 71601V105 | $68.4K | 3,088,000 | 0.0% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $66.4K | 421,860 | 0.0% |
| Welltower Inc(WELL) | COM | 95040Q104 | $66.4K | 927,040 | 0.0% |
| Ventas Inc(VTR) | COM | 92276F100 | $61.3K | 1,149,860 | 0.0% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $58.6K | 1,435,370 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $51.1K | 142,110 | 0.0% |
| Cooper COS Inc | COM NEW | 216648402 | $43.5K | 113,167 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $40.8K | 838,414 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $40.2K | 187,000 | 0.0% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $33.7K | 85,000 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $33.5K | 219,300 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $32.9K | 91,760 | 0.0% |
| Nuance Communications Inc | COM | 67020Y100 | $32.4K | 742,030 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $31.1K | 745,605 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $30.7K | 1,371,480 | 0.0% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $29.8K | 135,000 | 0.0% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $28.7K | 90,000 | 0.0% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $25.8K | 590,790 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $23.6K | 207,610 | 0.0% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $22.4K | 85,900 | 0.0% |
| Sotera Health Co(SHC) | COM | 83601L102 | $20.1K | 805,220 | 0.0% |
| Longview Acquisition Corp II | UNIT 99/99/9999 | 54319Q204 | $17.6K | 1,750,000 | 0.0% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $16.5K | 148,480 | 0.0% |